Combinatorial Screening of Nanoparticles for Nose-to-Brain RNA Delivery to Modulate Neuroinflammation after Traumatic Brain Injury
ACS Nano Medicine · 02.11.2026
DOI: 10.1021/acsnanomed.6c00153 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano Medicine, online erschienen am 02.11.2026. Verfasst von Yihan Xing und 6 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben. Gefördert von: Alzheimer's Association.
Abstract (Originalsprache)
Traumatic brain injury (TBI)-induced neuroinflammation can evolve over weeks or months, contributing to ongoing secondary damage and worsening neurological recovery. RNA-based therapeutics hold great potential to regulate inflammatory signaling, but delivery to the brain remains challenging because of the blood–brain barrier. Intranasal administration offers a direct, noninvasive route for brain access but is often limited by low delivery efficiency. Here, we constructed a combinatorial library of 103 DNA-barcoded lipid nanoparticles by varying lipid components with diverse headgroup chemistries and bioreactive moieties. A high-throughput screening of these nanoparticles in vivo following intranasal administration led to the identification of top candidates with the highest normalized DNA barcode brain delivery. Intranasal delivery of an antagomir targeting microRNA-9-5p loaded in a nanoparticle effectively reduced cerebral microRNA-9-5p levels, suppressed inflammatory markers, and improved neurological outcomes in TBI. These results demonstrate a systematic approach for optimizing intranasal lipid nanoparticle design and support the feasibility of RNA delivery to modulate neuroinflammation after brain injury.
Förderung
- Alzheimer's Association
Zitieren
APA
Xing, Y., Do, V., Xu, Z., Do, C., Yang, C., Zhu, Z., & Gao, J. (2026). Combinatorial Screening of Nanoparticles for Nose-to-Brain RNA Delivery to Modulate Neuroinflammation after Traumatic Brain Injury. ACS Nano Medicine. https://doi.org/10.1021/acsnanomed.6c00153
Vancouver
Xing Y, Do V, Xu Z, Do C, Yang C, Zhu Z, et al. Combinatorial Screening of Nanoparticles for Nose-to-Brain RNA Delivery to Modulate Neuroinflammation after Traumatic Brain Injury. ACS Nano Medicine. 2026. doi:10.1021/acsnanomed.6c00153
BibTeX
@article{Xing2026,
author = {Xing, Yihan and Do, Vy and Xu, Zunkai and Do, Clara and Yang, Canyuan and Zhu, Ziyue and Gao, Jingjing},
title = {Combinatorial Screening of Nanoparticles for Nose-to-Brain RNA Delivery to Modulate Neuroinflammation after Traumatic Brain Injury},
journal = {ACS Nano Medicine},
year = {2026},
doi = {10.1021/acsnanomed.6c00153}
}
EUVIMED